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http://dx.doi.org/10.1016/j.bgm.201Abstract This study aimed to investigate whether a methanolic extract of Scurrula atropur-
purea (BL.) Dans. (MESA) was able to reduced oxidative stress and systolic blood pressure (SBP)
in deoxycorticosterone acetateesalt hypertensive rats. Twenty-five male Wistar were divided
into the control group and four hypertensive groups that received the MESA at a doses of
50 mg/kg, 100 mg/kg, or 200 mg/kg bodyweight, or received no MESA. SBP was recorded by
tail cuff methods. The levels of serum malondialdehyde (MDA) and superoxide dismutase
(SOD) were analyzed by colorimetry. SBP was increased significantly in the hypertensive group
compared to the sham group (p < 0.05). Administration of MESA significantly decreased SBP,
but not to reach the level of the sham group. The level of MDA was significantly higher in
the hypertensive group compared to the sham group (p < 0.05). Administration of MESA200
significantly decreased the MDA levels compared to HR groups (p < 0.05). The SOD level was
significantly decreased in HR compared to the sham group (p < 0.05). Administration of MESA50
elevated the SOD levels to reach the level in the sham group. The SOD levels in MESA100 and
MESA200 were significantly higher compared to the sham group (p < 0.05). In conclusion,t of Biology, Faculty of Mathematic and Natural Sciences, Islamic University of Malang, Jalan MT
donesia.
yahoo.co.id (N. Athiroh).
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Scurrula atropurpurea in hypertensive rats 33Scurulla atropurpurea is able to modulate SOD, diminish oxidative stress, and decrease SBP in
deoxycorticosterone acetateesalt hypertensive rats.
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Hypertension is a clinical common vascular related disease,
with high mortality and disability. It is also an independent
risk factor for stroke, coronary heart disease, heart failure,
renal insufficiency, peripheral vascular diseases, early
death, and many other major diseases.1 Hypertension is the
misregulation of a complex interaction between genetic and
lifestyle factors affecting the physiological systems regu-
lating bloodpressure.2 There are about 1 billion hypertensive
patients in the world, and around 30% of the population die
from cardiovascular and cerebrovascular events, in which
62% of acute stroke events and 49% of cardiovascular events
are directly caused by hypertension.3,4
Consistent evidence reveals the involvement of reactive
oxygen species (ROS) and oxidative stress in hypertension
and its complications. Hypertension is associated with an
increased production of superoxide radicals that have a
negative effect on endothelial function. These effects are
based on the reaction between superoxide and nitric oxide
(NO) to decrease NO bioavailability. Peroxynitrites as the
products of this reaction, also have detrimental effects on
endothelial cells.5e7 Hydroxyl radicals as product decom-
position of hydroperoxynitrites may trigger lipid peroxida-
tion, as measured by increased malondialdehyde (MDA)
levels. Superoxide dismutase (SOD) plays an important role in
scavenging superoxide anions that are formed during the
early stages of oxidative stress, and in preventing aging.8 SOD
catalyzes the conversion of superoxide to hydrogen peroxide
plus dioxygen. SOD can be classified into three groups, Cu/Zn
SOD, Mn SOD, and Fe SOD, by themetals they contain at their
active sites. Cu/Zn SOD is usually found in the cytoplasm of
eukaryotic cells and Mn SOD in mitochondria, whereas pro-
karyotic cells contain Fe SOD and Mn SOD.9
For the decrease of hypertension and its complications,
many drugs of herbal origin have been produced, including
tetramethylpyrazine from Jathropha podagrica, tetran-
drine from Stephania tetrandra, digitoxin from Digitalis
purpurea, reserpine from Rauwolfia serpentina, and aspirin
from Salix alba.2,10,11 Scurrula atropurpurea (BL.) Dans. is a
parasite of tea plants. In Indonesia, especially on the island
of Java, the stems and leaves of this vegetation have been
traditionally used for the treatment of cancers.12 This study
aimed to investigate whether methanolic extract of Scur-
rula atropurpurea (BL.) Dans. (MESA) is able to diminish
oxidative stress in hypertensive rats.Materials and methods
Preparation of tea parasite crude extract
Scurrula atropurpurea was determined biologically at the
Indonesian Scientific Institute (LIPI) at Purwodadi, Pasuruan,East Java. MESA was obtained through several steps. The
leaves were washed, dried in an oven at 40e60C, then
ground into a powder. A 100 mg portion of this powder was
steeped in methanol in a 1 L Erlenmeyer flask. The mixture
was shaken for 30 minutes to distribute the powder homo-
genously in the methanol. To collect the precipitate, the
mixture was left to stand overnight. The upper layer know
and supernatant, being amixture ofmethanol and the active
constituents, was subjected to evaporation. The extract was
then labeled and stored in a freezer.13,14 This extract was
administered daily by oral gavage for 6 weeks.
Animals
Twenty-five male Wistar rats, aged 3e5 months, and
weighing 250e300 g were involved in this study. The rats
were divided into five groups (nZ 5 each): a control group,
a group of non-MESA hypertensive rats, and three groups of
hypertensive rats receiving MESA at dosages of 50 mg/kg,
100 mg/kg, or 200 mg/kg body weight. Hypertensive rats
were generated by injecting subcutaneously with deoxy-
corticosterone acetate (DOCA; Sigma Aldrich, Pte Ltd.,
Singapore, Singapore) at a dosage of 10 mg/kg body weight,
twice weekly for 6 weeks. The rats were given 2% NaCl
instead of drinking water. The blood pressure and the
weights of the rats were then determined.15
Blood pressure measurement
Systolic blood pressure (SBP) was recorded at the end of the
study by tail cuff methods (IITC Model 179, Non-Invasive
Blood Pressure Instrument, Woodland Hills, USA) according
to a previous study.16
Tissue sampling
At the end of the treatment, the animals in all groups were
anesthetized; their blood was drawn by cardiac puncture
and heparinized. Blood samples were centrifuged at 4000g
(4 minutes, 4C) to obtain the plasma. All samples were
stored at 80C until analysis.
MDA analysis
Plasma levels of MDA were determined as thiobarbituric
acid (TBA) reactive substance according to the method of
Ohkawa et al,17 based on the reaction of lipid peroxides
with TBA at 95 C. In the TBA test reaction, lipid peroxides
and TBA react to form a pink pigment with an absorption
maximum at 532 nm. The reaction was performed at pH
2e3 at 95C for 15 minutes. The sample was mixed with 2.5
volumes of 10% (w/v) trichloroacetic acid to precipitate the
protein. The precipitate was pelleted by centrifugation and
Figure 1 Systolic blood pressure in deoxycorticosterone
acetateesalt hypertensive rats (HR) with or without the
administration of methanolic Scurrula atropurpurea extract
(MESA) compared to the sham control group. There is signifi-
cantly (p < 0.05) increased systolic blood pressure in HR
compared to the sham group. Compared to its hypertensive
group, the administration of MESA significantly (p < 0.05)
decreased systolic blood pressure, but is not able to reach the
level in the sham group. * p < 0.05 in comparison with sham
group. ** p < 0.05 in comparison with deoxycorticosterone
acetateesalt hypertensive group.
Figure 2 Malondialdehyde in deoxycorticosterone acetatee
salt hypertensive rats (HR) with or without the administration
of methanolic Scurrula atropurpurea extract (MESA) compared
to the sham control group. There are significantly (p < 0.05)
increased MDA levels in HR compared to the sham group. The
administration of MESA200 significantly (p < 0.05) decreased
the malondialdehyde levels compared to HR groups. * p < 0.05
in comparison with sham group. ** p < 0.05 in comparison with
deoxycorticosterone acetateesalt hypertensive group.
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boiling water-bath for 15 minutes. After cooling, the
absorbance was read at 532 nm. Arbitrary values obtained
were compared with a series of standard solutions
(1,1,3,3 tetramethoxypropane). Results are expressed as
units/100 ml.
SOD analysis
SOD was assayed by measuring the inhibition of the for-
mation of blue-colored formazan at 560 nm according to
the technique of Kakkar et al.18 The inhibition by SOD of
reduction of nitro blue tetrazolium to blue-colored chro-
mogen in the presence of phenazine methosulfate and
nicotinamide adenine dinucleotide was measured at
560 nm. One unit of enzyme activity was defined as enzyme
concentration required to inhibit the absorbance at 560 nm
of chromogen production by 50% in 1 minute under assay
conditions, and expressed as specific activity in units of
SOD/minute/mg of protein.
Ethics
Animal care and experimental procedures were approved
by the Institutional Animal Ethics Committee of University
of Brawijaya, Malang, East Java, Indonesia.
Statistical analysis
Data are presented as mean  standard deviation and the
differences between groups were analyzed using one-way
analysis of variance (ANOVA) with SPSS version 15.0 (SPSS
Inc. Chicago, IL, USA). A post-hoc test was used if the
ANOVA was significant. Probability values of p < 0.05 were
considered statistically significant.
Results
Effect of MESA on SBP
The administration of DOCAesalt affected the SBP levels,
as shown in Fig. 1. There was significantly (p < 0.05)
increased SBP in hypertensive rats compared to the sham
group. Compared to the hypertensive group, the adminis-
tration of MESA significantly decreased SBP, but not to the
level of the sham group.
Effect of MESA on MDA level
The administration of DOCAesalt affected the MDA levels,
as shown in Fig. 2. There were significantly (p < 0.05)
increased MDA levels in hypertensive rats compared to the
sham group. The administration of MESA200 significantly
(p < 0.05) decreased the MDA levels compared to hyper-
tensive groups.
Effect of MESA on SOD level
The administration of DOCAesalt affected the serum SOD
levels, as shown in Fig. 3. The serum SOD levels weresignificantly (p < 0.05) decreased in hypertensive rats
compared to the sham group. The administration of MESA50
elevated the SOD levels to reach the level observed in the
sham group. The SOD levels in MESA100 and MESA200 were
significantly higher (p < 0.05) compared to the sham group.Discussion
Some species of Loranthaceae from China have been used
as medicinal materials for the treatment of hyperten-
sion.17,19 Various compounds have been found in Lor-
anthaceaeous plants and some of them have been
identified with hypotensive properties.12,20 In addition,
Taxillus theifer (Hayata) H. S. Kiu (Scurrula ritozanensis), a
Figure 3 The level of serum superoxide dismutase in
deoxycorticosterone acetateesalt hypertensive rats (HR)
with or without the administration of methanolic Scurrula
atropurpurea extract (MESA) compared to the sham control
group. The serum SOD level are significantly (p < 0.05)
decreased in HR compared to the sham group. The administra-
tion of MESA50 elevated the SOD levels to reach the level in
the sham group. The SOD levels in MESA100 and MESA200 were
higher significantly (p < 0.05) compared to HR group. * p < 0.05
in comparison with sham group. ** p < 0.05 in comparison with
deoxycorticosterone acetateesalt hypertensive group.
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as an antihypertensive agent in Formosan folk medicine.
The DOCAesalt treatment induced systemic arterial hy-
pertension, proteinuria, kidney hypertrophy, and impaired
kidney function, as reported for this model.22 This study
revealed that DOCAesalt treatment significantly (p < 0.05)
increased SBP as a marker of hypertensive rats compared to
the sham group. The administration of MESA significantly
decreased SBP, but this did not reach the level of the sham
group. This finding indicates there is no dose dependent
effect possibly due to the ability of kidney restoration. A
previous study showed that MESA reduces necrosis of the
renal proximal tubules achieved at doses of 50 mg/kg and
100 mg/kg body weight. At a higher dose, there is no sig-
nificant difference compared with the DOCAesalt treat-
ment group, that is, MESA at 200 mg/kg body weight may
induce a toxic effect on kidney.23
Oxidative stress in DOCAesalt-treated animals has been
studied with a variety of stress markers. Subunits of the
nicotinamide adenine dinucleotide phosphate oxidase were
found to be markedly expressed, the oxidative stress-
scavenging protein heme oxygenase-1 is upregulated and
also the urinary oxidative stress marker 8-isoprostane is
often increased.24,25 Additionally, there were increased
amounts of the oxidative base modification 7,8-dihydro-8-
oxo-guanine (which is now widely used as a marker of hy-
pertension in urine) in the DOCAesalt group.26 In this study,
the increase in blood MDA indicates an increase in oxidative
stress in DOCAesalt hypertensive rats. Depending on the
levels of reactive oxygen compounds, various transcription
factors sensitive to change in redox status will be activated
and will coordinate intracellular biological response.
Modest oxidative stress will induce Nrf2, a transcription
factor implicated in the transactivation of genes that
encode antioxidant enzymatic activity.27 The level of SOD
significantly (p < 0.05) decreased in DOCAesalt hyperten-
sive rats, indicating that they produce more superoxideradical. Oxidative stress has been implicated in the path-
ogenesis of Ang IIerelated hypertension.28,29 Ang II, through
AT1R, stimulates nicotinamide adenine dinucleotide phos-
phate oxidase, induces oxidative stress, and alters endo-
thelial cell function.30
The antioxidant compounds of Scurrula atropurpurea
extract in our study may include quercetin, quercetin-3-O-
glucoside, quercitrin (a glycoside rhamnose of quercetin),
and kaempferol. Quercetin exerts its antioxidant activity
through scavenging reactive oxygen speces.31,32 Quercitrin
also has a free radical scavenging activity.33 Kaempferol has
shown a strong inhibitory/scavenging activity on ROS gen-
eration with numerous hydroxyl groups on their struc-
tures.33 Moreover, it has been found to be a particularly
potent blocker of extracellular ROS production, and to
inhibit the ascorbate-dependent NADH oxidase and super-
oxide anion production activities.34 Therefore, the MDA-
lowering effect and modulation of SOD by Scurrula atro-
purpurea extract demonstrated in this study might have
been associated with flavonol or phenolic compounds.
In conclusion, Scurrula atropurpurea is able to modulate
SOD, diminish oxidative stress, and decrease SBP in
DOCAesalt hypertensive rats.Conflicts of interest
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